Published in Circulation on January 01, 1978
Accurate detection of coronary heart disease by new exercise test. Br Heart J (1982) 2.97
Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm. Br Heart J (1985) 1.58
Value of the bipolar lead CM5 in electrocardiography. Br Heart J (1986) 1.08
Normal coronary arteriogram. An avoidable test? Br Heart J (1982) 1.00
Detection of high risk coronary artery disease by thallium imaging. Br Heart J (1985) 0.95
Diagnostic value of routine exercise testing in hospital patients with angina pectoris. Br Med J (1979) 0.86
Exercise testing in men with significant left main coronary disease. Br Heart J (1979) 0.80
A novel method to capture the onset of dynamic electrocardiographic ischemic changes and its implications to arrhythmia susceptibility. J Am Heart Assoc (2014) 0.77
Evaluation of the exercise electrocardiogram by the ST segment/heart rate slope. Bull N Y Acad Med (1987) 0.77
Left ventricular volume determined by radionuclide techniques: a review. West J Med (1981) 0.75
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet (1997) 4.65
Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med (1989) 4.02
Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. Circulation (1976) 3.11
Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 2.85
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. N Engl J Med (1990) 2.73
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med (1984) 2.70
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56
Complication rate of coronary arteriography. A review of 5250 cases studied by a percutaneous femoral technique. Circulation (1976) 2.40
Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med (1999) 2.39
The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol (1998) 2.38
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J (2001) 2.30
Social support, depression, and mortality during the first year after myocardial infarction. Circulation (2000) 2.25
Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation (1990) 2.13
The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med (2000) 2.11
Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11
Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol (2000) 2.04
Blood pressure reduction in "borderline" hypertensives following physical training. Can Med Assoc J (1973) 2.03
Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation (1992) 1.99
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med (1979) 1.79
Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation (1982) 1.79
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis (1993) 1.75
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74
ECG phenomenon called the J wave. History, pathophysiology, and clinical significance. J Electrocardiol (1995) 1.73
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72
Myocardial bridging and milking effect of the left anterior descending coronary artery: normal variant or obstruction? Am J Cardiol (1976) 1.71
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) Circulation (1998) 1.67
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol (1993) 1.66
Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol (1998) 1.64
The importance of clinical subsets in interpreting maximal treadmill exercise test results: the role of multiple-lead ECG systems. Circulation (1979) 1.61
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol (1992) 1.59
Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res (2000) 1.57
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56
Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med (1994) 1.56
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Circulation (1995) 1.56
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol (1998) 1.55
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation (2000) 1.55
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc (1997) 1.52
Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation (1998) 1.51
Better functional status in American than Canadian patients with heart disease: an effect of medical care? J Am Coll Cardiol (1995) 1.50
Evaluation of patients with chest pain and normal coronary angiograms. Arch Intern Med (2001) 1.48
Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation (1984) 1.48
Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol (1989) 1.47
Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. J Am Coll Cardiol (1998) 1.44
Comparison of the Asymptomatic Cardiac Ischemia Pilot and modified Asymptomatic Cardiac Ischemia Pilot versus Bruce and Cornell exercise protocols. Am J Cardiol (1993) 1.44
Prognostic value of dipyridamole thallium-201 imaging in elderly patients. J Am Coll Cardiol (1992) 1.43
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol (1994) 1.43
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol (1996) 1.41
Skeletal muscle adaptation in adolescent boys: sprint and endurance training and detraining. Med Sci Sports Exerc (1982) 1.39
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation (1999) 1.39
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol (1994) 1.34
Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease. Am J Cardiol (1973) 1.33
Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet (1994) 1.32
Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation (1995) 1.32
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol (1996) 1.31
Institutional differences in therapeutic decision making in the Coronary Artery Surgery Study (CASS). Med Decis Making (1986) 1.31
uvrA is an acid-inducible gene involved in the adaptive response to low pH in Streptococcus mutans. J Bacteriol (2001) 1.30
Biocompatibility aspects of new stent technology. J Am Coll Cardiol (1998) 1.30
Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am J Cardiol (1978) 1.26
Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation (1982) 1.22
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. J Am Coll Cardiol (1995) 1.22
Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation (1983) 1.21
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation (1985) 1.17
Influence of aortocoronary saphenous vein bypass surgery on left ventricular volumes and ejection fraction. Comparison before and one year after surgery in 51 patients. Am J Med (1973) 1.17
Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res (1995) 1.15
Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation (1983) 1.14
Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation (1979) 1.14
Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol (2001) 1.14
Effects of carbon monoxide on myocardial ischemia. Environ Health Perspect (1991) 1.13
The effects of inhalation of 100 percent oxygen on myocardial lactate metabolism in coronary heart disease. Am J Cardiol (1969) 1.12
Serial angiograpic evaluation in 60 consecutive patients with aorto-coronary artery vein grafts 2 weeks, 1 year, and 3 years after operation. J Thorac Cardiovasc Surg (1974) 1.10
Cervical spondylitic myelopathy. Neurol Clin (1985) 1.09
Selective coronary arteriography by the percutaneous femoral artery approach. Am J Roentgenol Radium Ther Nucl Med (1969) 1.09
Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation (1974) 1.09